SHAMAN PHARMACEUTICALS INC
SC 13G/A, 2000-03-08
PHARMACEUTICAL PREPARATIONS
Previous: SI DIAMOND TECHNOLOGY INC, 4, 2000-03-08
Next: MUNICIPAL INVT TR FD MON PYMT SER 535 DEFINED ASSET FDS, 485BPOS, 2000-03-08



<PAGE>
									OMB APPROVAL

							OMB Number:3235-0145
							Expires:  August 31, 1999
							Estimated average burden
							hours per response 1-0-0

						UNITED STATES
				SECURITIES AND EXCHANGE COMMISSION
					Washington, D.C. 20549

						SCHEDULE 13G

			Under the Securities Exchange Act of 1934
					  (Amendment No. 1)

				  Shaman Pharmaceuticals, Inc.
					  (Name of Issuer)

						Common Stock
				(Title of Class of Securities)

						 81931910
					   (CUSIP Number)

					   March 1, 2000
		(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:

					/____/	Rule 13d-1(b)
					/XXX/	Rule 13d-1(c)
					/___/	Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).

Potential persons who are to respond to the collection of information
contained in this form are not required to respond unless the form
displays a currently valid OMB control number.
SEC 1745 (3-98)			Page 1 of 10

<PAGE>
CUSIP No. 81931910				13G				Page 2 of 10 Pages

- ----------------------------------------------------------------
1	NAME OF REPORTING PERSONS
	IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

	Tradewinds Financial Corporation
- ----------------------------------------------------------------
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
	(a)/XX/
	(b)/  /
- ----------------------------------------------------------------
3	SEC USE ONLY

- ----------------------------------------------------------------
4	CITIZENSHIP OR PLACE OF ORGANIZATION

	California
- ----------------------------------------------------------------
	  NUMBER OF	5	SOLE VOTING POWER
	   SHARES			-0-
	BENEFICIALLY		---------------------------------------
	  OWNED BY	6	SHARED VOTING POWER
	    EACH			2,906,990
	 REPORTING		---------------------------------------
	   PERSON		7	SOLE DISPOSITIVE POWER
	    WITH			-0-
					---------------------------------------
				8	SHARED DISPOSITIVE POWER
					2,906,990
- ----------------------------------------------------------------
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	2,906,990
- ----------------------------------------------------------------
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
	SHARES (See Instructions)

- ----------------------------------------------------------------
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
	8.54%
- ----------------------------------------------------------------
12	TYPE OF REPORTING PERSON (See Instructions)
	IA, CO
- ----------------------------------------------------------------

<PAGE>
CUSIP No. 81931910				13G				Page 3 of 10 Pages

- ----------------------------------------------------------------
1	NAME OF REPORTING PERSONS
	IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

	Tradewinds Debt Strategies Fund, L.P.
- ----------------------------------------------------------------
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
	(a)/XX/
	(b)/  /
- ----------------------------------------------------------------
3	SEC USE ONLY

- ----------------------------------------------------------------
4	CITIZENSHIP OR PLACE OF ORGANIZATION

	California
- ----------------------------------------------------------------
	  NUMBER OF	5	SOLE VOTING POWER
	   SHARES			-0-
	BENEFICIALLY		---------------------------------------
	  OWNED BY	6	SHARED VOTING POWER
	    EACH			1,657,107
	 REPORTING		---------------------------------------
	   PERSON		7	SOLE DISPOSITIVE POWER
	    WITH			-0-
					---------------------------------------
				8	SHARED DISPOSITIVE POWER
					1,657,107
- ----------------------------------------------------------------
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	1,657,107
- ----------------------------------------------------------------
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
	SHARES (See Instructions)

- ----------------------------------------------------------------
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
	4.87%
- ----------------------------------------------------------------
12	TYPE OF REPORTING PERSON (See Instructions)
	PN
- ----------------------------------------------------------------

<PAGE>
CUSIP No. 81931910				13G				Page 4 of 10 Pages

- ----------------------------------------------------------------
1	NAME OF REPORTING PERSONS
	IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

	Feehan Partners, L.P.
- ----------------------------------------------------------------
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
	(a)/XX/
	(b)/  /
- ----------------------------------------------------------------
3	SEC USE ONLY

- ----------------------------------------------------------------
4	CITIZENSHIP OR PLACE OF ORGANIZATION

	California
- ----------------------------------------------------------------
	  NUMBER OF	5	SOLE VOTING POWER
	   SHARES			-0-
	BENEFICIALLY		---------------------------------------
	  OWNED BY	6	SHARED VOTING POWER
	    EACH			839,459
	 REPORTING		---------------------------------------
	   PERSON		7	SOLE DISPOSITIVE POWER
	    WITH			-0-
					---------------------------------------
				8	SHARED DISPOSITIVE POWER
					839,459
- ----------------------------------------------------------------
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	839,459
- ----------------------------------------------------------------
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
	SHARES (See Instructions)

- ----------------------------------------------------------------
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
	2.47%
- ----------------------------------------------------------------
12	TYPE OF REPORTING PERSON (See Instructions)
	PN
- ----------------------------------------------------------------

<PAGE>
CUSIP No. 81931910				13G				Page 5 of 10 Pages

- ----------------------------------------------------------------
1	NAME OF REPORTING PERSONS
	IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

	Scott P. Peters
- ----------------------------------------------------------------
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
	(a)/XX/
	(b)/  /
- ----------------------------------------------------------------
3	SEC USE ONLY

- ----------------------------------------------------------------
4	CITIZENSHIP OR PLACE OF ORGANIZATION

	United States of America
- ----------------------------------------------------------------
	  NUMBER OF	5	SOLE VOTING POWER
	   SHARES			1,341,011
	BENEFICIALLY		---------------------------------------
	  OWNED BY	6	SHARED VOTING POWER
	    EACH			3,105,582
	 REPORTING		---------------------------------------
	   PERSON		7	SOLE DISPOSITIVE POWER
	    WITH			1,341,011
					---------------------------------------
				8	SHARED DISPOSITIVE POWER
					3,105,582
- ----------------------------------------------------------------
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	4,446,593
- ----------------------------------------------------------------
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
	SHARES (See Instructions)

- ----------------------------------------------------------------
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
	13.06%
- ----------------------------------------------------------------
12	TYPE OF REPORTING PERSON (See Instructions)
	IN, HC
- ----------------------------------------------------------------

<PAGE>
CUSIP No. 81931910				13G				Page 6 of 10 Pages

- ----------------------------------------------------------------
1	NAME OF REPORTING PERSONS
	IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

	Robert W. Scannell
- ----------------------------------------------------------------
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
	(a)/XX/
	(b)/  /
- ----------------------------------------------------------------
3	SEC USE ONLY

- ----------------------------------------------------------------
4	CITIZENSHIP OR PLACE OF ORGANIZATION

	United States of America
- ----------------------------------------------------------------
	  NUMBER OF	5	SOLE VOTING POWER
	   SHARES			425,553
	BENEFICIALLY		---------------------------------------
	  OWNED BY	6	SHARED VOTING POWER
	    EACH			3,824,970
	 REPORTING		---------------------------------------
	   PERSON		7	SOLE DISPOSITIVE POWER
	    WITH			425,553
					---------------------------------------
				8	SHARED DISPOSITIVE POWER
					3,824,970
- ----------------------------------------------------------------
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	4,250,524
- ----------------------------------------------------------------
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
	SHARES (See Instructions)

- ----------------------------------------------------------------
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
	12.48%
- ----------------------------------------------------------------
12	TYPE OF REPORTING PERSON (See Instructions)
	IN, HC
- ----------------------------------------------------------------


<PAGE>
CUSIP No. 81931910				13G			Page 7 of 10 Pages

ITEM 1.

	(a)	The name of the issuer is Shaman Pharmaceuticals, Inc. (the
"Issuer").

	(b)	The principal executive office of the Issuer is located at 213
East Grand Avenue, South San Francisco, CA  94080.

ITEM 2.

This Amendment No. 1 amends and supplements the Statement on Schedule 13G
filed by Tradewinds Financial Corporation, ("Tradewinds"), Tradewinds Debt
Strategies Fund, L.P. ("DSF"), Feehan Partners, L.P. ("Feehan"), Scott P.
Peters ("Peters") and Robert W. Scannell ("Scannell") (collectively, the
"Filers"), on February 1, 2000.  This amendment relates to the common
stock, $0.001 par value per share (the "Common Stock"), of Shaman
Pharmaceuticals, Inc., a Delaware corporation (the "Issuer").  According
to the Issuer, as of March 2, 2000, there were 34,048,345 shares of Common
Stock outstanding.

Only those items amended are reported herein.  Capitalized terms not
defined herein have the meaning ascribed to them in the Schedule 13G.

In addition to the shares of Common Stock beneficially owned by the Filers
and reported in the Schedule 13G filed on February 1, 2000, each of the
Filers beneficially owns Stock Purchase Warrants (the "Warrants")
exercisable for shares of Common Stock of the Issuer and Convertible
Promissory Notes (the "Notes") convertible into shares of Common Stock of
the Issuer.  Because the Warrants are exercisable and the Notes are
convertible within 60 days, the Filers may be deemed to beneficially own
the number of shares of Common Stock into which the Warrants are
exercisable and the Notes are convertible.  The Warrants become
exercisable at any time after April 30, 2000, and on or before April 30,
2005.  The Notes automatically convert to Common Stock of the Issuer on
May 1, 2000, if the Issuer's wholly-owned subsidiary does not consummate
an equity financing on or before April 30, 2000, resulting in gross
aggregate proceeds to the subsidiary of a specified amount.  If the
subsidiary consummates an equity financing on or before April 30, 2000,
resulting in gross aggregate proceeds that meet the minimum specified
amount, then the Notes and any accrued or unpaid interest therein shall be
automatically converted into either Common Stock of the Issuer or capital
stock of the subsidiary, at the option of the holder of the Note.  The
number of shares of Common Stock into which the Warrants will be
exercisable and the Notes will be convertible is based on the per share
conversion price of the Issuer's Series R Preferred Stock on February 1,
2000, reported by the Issuer to be .497.


 <PAGE>

CUSIP No. 81931910				13G			Page 8 of 10 Pages

ITEM 2. (continued)

As the sole trustee of a defined contribution plan of an affiliate of
Tradewinds, Mr. Peters has sole voting and dispositive power over the
shares of the Issuer's Common Stock that the defined contribution plan has
the right to acquire within 60 days pursuant to its Warrant and its Note.
Therefore, Mr. Peters may be deemed the beneficial owner of such shares.
Although Mr. Scannell has reported beneficial ownership of the number of
shares of the Issuer's Common Stock held by the defined contribution plan
equal to Mr. Scannell's interest in the plan as of the date of this
filing, Mr. Scannell disclaims beneficial ownership of such shares.

As the sole general partner of Feehan, Mr. Scannell shares voting and
dispositive power with Feehan over the shares of the Issuer's Common Stock
owned by Feehan.  Therefore, Mr. Scannell may be deemed the beneficial
owner of such shares.


ITEM 3.  If this statement is filed pursuant to rule 240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a:

	(a)	___	Broker or dealer registered under section 15 of the Act (15
U.S.C. 78o).

	(b)	___	Bank as defined in section 3(a)(6) of the Act (15 U.S.C.
78c).

	(c)	___	Insurance company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c).

	(d)	___	Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C. 80a-8).

	(e)	___	An investment adviser in accordance with 240.13d-
1(b)(1)(ii)(E).

	(f)	___	An employee benefit plan or endowment fund in accordance
with 240.13d-1(b)(1)(ii)(F).

	(g)	___	A parent holding company or control person in accordance
with 240.13d-1(b)(1)(ii)(G)

	(h)	___	A savings association as defined in section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813).

<PAGE>

CUSIP No. 81931910				13G			Page 9 of 10 Pages


ITEM 3 (continued)

	(i)	___	A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment Company Act of
1940 (15 U.S.C. 80a-3).

	(j)	___	Group, in accordance with section 240.13d-1(b)(1)(ii)(J)


ITEM 4.  OWNERSHIP

See Items 5-9 and 11 on the cover page for each Filer.


ITEM 5.  OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the following /___/.


ITEM 6.  OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

Tradewinds is an investment adviser whose clients have the right to
receive or the power to direct the receipt of dividends from, or the
proceeds from the sale of, the Stock.


ITEM 7.  IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

Not applicable.


ITEM 8.  IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

See Item 2(a) of this Schedule.


ITEM 9.  NOTICE OF DISSOLUTION OF GROUP

Not applicable.


 <PAGE>

CUSIP No. 81931910				13G			Page 10 of 10 Pages

ITEM 10.  CERTIFICATION

By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control
of the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose
or effect.

						SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.

Dated:	February 10, 2000

Tradewinds Financial Corporation		Tradewinds Debt
								  Strategies Fund, L.P.


	/s/ Robert W. Scannell				/s/ Robert W. Scannell
By	Robert W. Scannell				By	Robert W. Scannell
	President							President


Feehan Partners, L.P.


	/s/ Robert W. Scannell
By	Robert W. Scannell
	General Partner



/s/ Robert W. Scannell			/s/ Scott P. Peters
Robert W. Scannell				Scott P. Peters


CRK/4118/002/1089902



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission